No results for ‘’
3B Blackbio DX Ltd
NSE: BSE: 532067
â‚ą1419.90
(1.62%)
Sun, 13 Sept 2026, 09:17 am
Market Cap (in Cr)1241.4
PE Ratio21.95
Dividend0.28
Process Industries
Chemicals: Agricultural
24.5K3B Blackbio DX Analysis
dividend
- Dividends paid are thoroughly covered by earnings (18.3x coverage).
- Kilpest India has only been paying a dividend for 9 years, and since then dividends per share have fallen.
- Kilpest India has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
- Kilpest India's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Kilpest India's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Kilpest India is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Kilpest India is profitable, therefore cash runway is not a concern.
- Kilpest India is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (112.3%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 11.9x debt.
- Kilpest India's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (71.4% vs 9.9% today).
- Interest payments on debt are well covered by earnings (EBIT is 24.8x coverage).
- Kilpest India's level of debt (9.9%) compared to net worth is satisfactory (less than 40%).
- High level of physical assets or inventory.
management
- The tenure for the Kilpest India board of directors is about average.
- Ram Kuber's remuneration is lower than average for companies of similar size in India.
- Ram Kuber's compensation has been consistent with company performance over the past year, both up more than 20%.
misc
- Kilpest India is not covered by any analysts.
- Kilpest India has significant price volatility in the past 3 months.
past
- Kilpest India has delivered over 20% year on year earnings growth in the past 5 years.
- Kilpest India used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Kilpest India has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Kilpest India has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Kilpest India's earnings growth has exceeded the IN Chemicals industry average in the past year (37.3% vs 9.1%).
- Kilpest India's 1-year earnings growth is less than its 5-year average (37.3% vs 56.2%)
value
- 532067 outperformed the Chemicals industry which returned 2.2% over the past year.
- 532067 outperformed the Market in India which returned -14.5% over the past year.
- Kilpest India's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Kilpest India's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Kilpest India is overvalued based on assets compared to the IN Chemicals industry average.
- Kilpest India is overvalued based on earnings compared to the IN Chemicals industry average.
- Kilpest India is overvalued based on earnings compared to the India market.
- BSE:532067 is up 4.5% underperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:532067 is up 4.5% underperforming the market in India which returned 8% over the past month.